Informing on prenatal screening for Down syndrome prior to conception. An empirical and ethical perspective

American Journal of Medical Genetics, Part A

Volumn 158 A, Issue 3, 2012, Pages 485-497

  Schoonen, Marleen ^a   van der Zee, Boukje ^a   Wildschut, Hajo ^a   de Beaufort, Inez ^a   de Wert, Guido ^b   de Koning, Harry ^a   Essink Bot, Marie Louise ^c   Steegers, Eric ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Down syndrome; Information on prenatal screening; Informed decision making; Medical ethics; Preconception care consultation; Right not to know

Indexed keywords

ACCESS TO INFORMATION; ADULT; ARTICLE; DECISION MAKING; DOWN SYNDROME; FEMALE; GENETIC COUNSELING; HUMAN; INFORMATION DISSEMINATION; MATERNAL CARE; MEDICAL ETHICS; PATIENT PREFERENCE; PATIENT RIGHT; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL;

DECISION MAKING; DOWN SYNDROME; EMPIRICAL RESEARCH; HUMANS; NETHERLANDS; PRECONCEPTION CARE; PRENATAL DIAGNOSIS; QUESTIONNAIRES; UNITED STATES;

EID: 84857117330     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35213     Document Type: Article

References (87)

1. Alderliesten ME, Vrijkotte TG, van der Wal MF, Bonsel GJ. 2007. Late start of antenatal care among ethnic minorities in a large cohort of pregnant women. BJOG 114: 1232-1239.
2. Alderson P. 2001. Prenatal screening, ethics and down's syndrome: A literature review. Nurs Ethics 8: 360-374.
3. Al-Jader LN, Parry-Langdon N, Smith RJ. 2000. Survey of attitudes of pregnant women towards down syndrome screening. Prenat Diagn 20: 23-29.
4. American College of Obstetricians and Gynecologists. 2005. ACOG committee opinion number 313, September 2005. the importance of preconception care in the continuum of women's health care. Obstet Gynecol 106: 665-666.
5. American College of Obstetricians and Gynecologists. 2007a. ACOG practice bulletin no. 77: Screening for fetal chromosomal abnormalities. Obstet Gynecol 109: 217-227.
6. American College of Obstetricians and Gynecologists. 2007b. ACOG practice bulletin no. 88, december 2007. Invasive prenatal testing for aneuploidy. Obstet Gynecol 110: 1459-1467.
7. Andorno R. 2004. The right not to know: An autonomy based approach. J Med Ethics 30: 435-439 (discussion 439-40).
8. Barry MJ. 2002. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med 136: 127-135.
9. Beauchamp T, Childress J. 1989. Principles of biomedical ethics. Oxford: Oxford University Press.
10. Bekker H, Thornton JG, Airey CM, Connelly JB, Hewison J, Robinson MB, Lilleyman J, MacIntosh M, Maule AJ, Michie S, Pearman AD. 1999. Informed decision making: An annotated bibliography and systematic review. Health Technol Assess 3: 1-156.
11. Bekker HL, Hewison J, Thornton JG. 2004. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for down syndrome: A randomised controlled trial. Prenat Diagn 24: 265-275.
12. Bombard Y, Miller FA, Hayeems RZ, Avard D, Knoppers BM. 2010. Reconsidering reproductive benefit through newborn screening: A systematic review of guidelines on preconception, prenatal and newborn screening. Eur J Hum Genet. 18: 751-760.
13. Borry P, Henneman L, Lakeman P, ten Kate LP, Cornel MC, Howard HC. 2011. Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Hum Reprod 26: 972-977.
14. Boyd PA, Devigan C, Khoshnood B, Loane M, Garne E, Dolk H. EUROCAT Working Group. 2008. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and down's syndrome. BJOG 115: 689-696.
15. Broussard DL, Sappenfield WB, Fussman C, Kroelinger CD, Grigorescu V. 2011. Core state preconception health indicators: A voluntary, multi-state selection process. Matern Child Health J 15: 158-168.
16. Buckley F, Buckley S. 2008. Wrongful deaths and rightful lives-Screening for down syndrome. Downs Syndr Res Pract 12: 79-86.
17. Centers for Disease Control and Prevention (CDC). 2006. National Center on Birth Defects and Developmental Disabilities. Preconception health and care, 2006.
18. Chervenak FA, McCullough LB. 2010. Ethical considerations in first-trimester down syndrome risk assessment. Curr Opin Obstet Gynecol 22: 135-138.
19. Chervenak FA, McCullough LB, Chasen ST. 2005. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21. Semin Perinatol 29: 277-279.
20. Consensus Group Statement. (National Down Syndrome Society-NDSS, National Down Syndrome Congress-NDSC, American College of Obstetricians and Gynecologists-ACOG, American College of Medical Genetics-ACMG, National Society of Genetic Counselors-NSGC). 2009. Toward concurrence: Understanding prenatal screening and diagnosis of down syndrome from the health professional and advocacy community perspective.
21. de Jong A, Dondorp WJ, de Die-Smulders CE, Frints SG, de Wert GM. 2010. Non-invasive prenatal testing: Ethical issues explored. Eur J Hum Genet 18: 272-277.
22. de Weerd S, Steegers EA. 2002. The past and present practices and continuing controversies of preconception care. Community Genet 5: 50-60.
23. Dormandy E, Michie S, Hooper R, Marteau TM. 2005. Low uptake of antenatal down syndrome screening in ethnic and socially deprived groups: A reflection of women's attitudes or a failure to facilitate informed choices? Int J Epidemiol 34: 346-352.
24. Driscoll DA, Morgan MA, Schulkin J. 2009. Screening for down syndrome: Changing practice of obstetricians. Am J Obstet Gynecol 200: 459.e1-459.e9.
25. Ende J, Kazis L, Ash A, Moskowitz MA. 1989. Measuring patients' desire for autonomy: Decision making and information-seeking preferences among medical patients. J Gen Intern Med 4: 23-30.
26. EUROCAT. 2010. Special report: Prenatal screening policies in europeEUROCAT Publications on Prenatal Diagnosis.
27. Flanagan SM, Hancock B. 2010. 'Reaching the hard to reach'-Lessons learned from the VCS (voluntary and community sector). A qualitative study. BMC Health Serv Res 10: 92.
28. Fransen MP, Essink-Bot ML, Vogel I, Mackenbach JP, Steegers EA, Wildschut HI. 2010. Ethnic differences in informed decision-making about prenatal screening for down's syndrome. J Epidemiol Community Health 64: 262-268.
29. Fransen MP, Hajo W, Vogel I, Mackenbach J, Steegers E, Essink-Bot ML. 2009. Information about prenatal screening for down syndrome: Ethnic differences in knowledge. Patient Educ Couns 77: 279-288.
30. Freda MC, Moos MK, Curtis M. 2006. The history of preconception care: Evolving guidelines and standards. Matern Child Health J 10: S43-S52.
31. Garcia E, Timmermans DR, van Leeuwen E. 2008. The impact of ethical beliefs on decisions about prenatal screening tests: Searching for justification. Soc Sci Med 66: 753-764.
32. Garcia E, Timmermans DR, van Leeuwen E. 2009. Reconsidering prenatal screening: An empirical-ethical approach to understand moral dilemmas as a question of personal preferences. J Med Ethics 35: 410-414.
33. Gekas J, Gagne G, Bujold E, Douillard D, Forest JC, Reinharz D, Rousseau F. 2009. Comparison of different strategies in prenatal screening for down's syndrome: Cost effectiveness analysis of computer simulation. BMJ 338: b138.
34. Gekas J, Gondry J, Mazur S, Cesbron P, Thepot F. 1999. Informed consent to serum screening for down syndrome: Are women given adequate information? Prenat Diagn 19: 1-7.
35. General Medical Council. 1999. Seeking patients' consent: The ethical considerations. London: GMC.
36. Goldberg H. 2009. Informed decision making in maternity care. J Perinat Educ 18: 32-40.
37. Gourounti K, Sandall J. 2008. Do pregnant women in Greece make informed choices about antenatal screening for down's syndrome? A questionnaire survey. Midwifery 24: 153-162.
38. Green JM, Hewison J, Bekker HL, Bryant LD, Cuckle HS. 2004. Psychosocial aspects of genetic screening of pregnant women and newborns: A systematic review. Health Technol Assess 8: iii, ix-x, 1-109.
39. Guadagnoli E, Ward P. 1998. Patient participation in decision-making. Soc Sci Med 47: 329-339.
40. Hartley NE, Scotcher D, Harris H, Williamson P, Wallace A, Craufurd D, Harris R. 1997. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet 34: 459-464.
41. Health Council of the Netherlands. 2001. Prenatal screening: Down's syndrome, neural tube defects, routine-ultrasonography. 11.
42. Health Council of the Netherlands. 2004. Prenatal screening (2); down's syndrome, neural tube defects. Health Council of the Netherlands 2004/06.
43. Health Council of the Netherlands. 2007a. Population screening act. prenatal screening on down's syndrome and neural tube defects. Health Council of the Netherlands 2007/05.
44. Health Council of the Netherlands. 2007b. Preconception care: A good beginning. The Hague: Health Council of the Netherlands.
45. Hesselink AE, Verhoeff AP, Stronks K. 2009. Ethnic health care advisors: A good strategy to improve the access to health care and social welfare services for ethnic minorities? J Community Health 34: 419-429.
46. Holmes-Rovner M, Wills CE. 2002. Improving informed consent: Insights from behavioral decision research. Med Care 40: V30-V38.
47. Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS, Boulet S, Curtis MG. CDC/ATSDR Preconception Care Work Group, Select Panel on Preconception Care. 2006. Recommendations to improve preconception health and health care-United States. A report of the CDC/ATSDR preconception care work group and the select panel on preconception care. MMWR Recomm Rep 55: 1-23.
48. Joint Working Party of the Royal College of Obstetricians and Gynaecologists and the Royal College of Paediatrics and Child Health. 1997. Fetal abnormalities-guidelines for screening, diagnosis and management: Report of a joint working party of the Royal College of Obstetricians and Gynaecologists and the Royal College of Paediatrics and Child Health. RCOG Press.
49. Katz Rothman B. 1986. The tentative pregnancy. New York: Viking.
50. Kohut RJ, Dewey D, Love EJ. 2002. Women's knowledge of prenatal ultrasound and informed choice. J Genet Couns 11: 265-276.
51. Kuc S, Koster MP, Visser GH, Schielen PC. 2010. Performance of first-trimester serum screening for trisomy 21 before and from 11+0 weeks of gestational age in the Netherlands. Prenat Diagn 30: 906-908.
52. Laurie G. 2001. Genetic privacy: A challenge to medico-legal norms. Cambridge: Cambridge University Press.
53. Lindeman R. 2008. Take down syndrome out of the abortion debate. CMAJ 179: 1088.
54. Livingood WC, Brady C, Pierce K, Atrash H, Hou T, Bryant T III. 2010. Impact of pre-conception health care: Evaluation of a social determinants focused intervention. Matern Child Health J 14: 382-391.
55. Marteau TM, Dormandy E, Michie S. 2001. A measure of informed choice. Health Expect 4: 99-108.
56. Michie S, Dormandy E, Marteau TM. 2002. The multi-dimensional measure of informed choice: A validation study. Patient Educ Couns 48: 87-91.
57. National Center for Health Statistics. 2011. Health, United States, 2010. Hyattsville: National Center for Health Statistics.
58. National Screening Committee. 2000. Second report of the UK national screening committee. London: Department of Health.
59. National Society of Genetic Counselors. 1992. The NSGC code of ethics. J Genet Counsel 1: 41-44.
60. Nicolaides KH. 2003. Screening for chromosomal defects. Ultrasound Obstet Gynecol 21: 313-321.
61. O'Connor A, O'Brien Pallas LL. 1989. Decisional conflict. In: McFarlane GK, McFarlane EA, editors. Nursing diagnosis and intervention. Toronto: Mosby. pp 486-496.
62. Palomaki GE, Bradley LA, McDowell GA. Down Syndrome Working Group, ACMG Laboratory Quality Assurance Committee. 2005. Technical standards and guidelines: Prenatal screening for down syndrome. Genet Med 7: 344-354.
63. Parens E, Asch A. 2003. Disability rights critique of prenatal genetic testing: Reflections and recommendations. Ment Retard Dev Disabil Res Rev 9: 40-47.
64. Reynolds TM. 2000. Down's syndrome screening: A controversial test, with more controversy to come! J Clin Pathol 53: 893-898.
65. Reynolds TM. 2003. Down's syndrome screening is unethical: Views of today's research ethics committees. J Clin Pathol 56: 268-270.
66. Rimer BK, Briss PA, Zeller PK, Chan EC, Woolf SH. 2004. Informed decision making: What is its role in cancer screening? Cancer 101: 1214-1228.
67. Roelofsen EE, Kamerbeek LI, Tymstra TJ, Beekhuis JR, Mantingh A. 1993. Women's opinions on the offer and use of maternal serum screening. Prenat Diagn 13: 741-747.
68. Royal College of Obstetricians and Gynaecologists. 2005. Amniocentesis and chorionic villus sampling. London: Royal College of Obstetricians and Gynaecologists.
69. Savulescu J, Kahane G. 2009. The moral obligation to create children with the best chance of the best life. Bioethics 23: 274-290.
70. Schoonen HM, Wildschut HIJ, Essink-Bot ML, Peters IA, Steegers E, de Koning HJ. 2011a. The provision of information and informed decision-making on prenatal screening for Down syndrome: A questionnaire- and register-based survey in a non-selected population. Patient Educ Couns Published Online 24 Oct 2011 at: DOI: 10.1016/2011.10.001.
71. Schoonen HMHJD, van Agt HME, Essink-Bot ML, Wildschut HI, Steegers EAP, de Koning HJ. 2011b. Informed decision-making in prenatal screening for down's syndrome: What knowledge is relevant. Patient Educ Couns 84: 265-270.
72. Seavilleklein V. 2009. Challenging the rhetoric of choice in prenatal screening. Bioethics 23: 68-77.
73. Seror V, Costet N, Ayme S. 2000. Prenatal screening for trisomy 21 with maternal serum markers: Information for decision-making in pregnant women. J Gynecol Obstet Biol Reprod (Paris) 29: 492-500.
74. Skirton H, Barr O. 2009. Antenatal screening and informed choice: A cross-sectional survey of parents and professionals. Midwifery 26: 596-602.
75. Stiggelbout AM, Molewijk AC, Otten W, Timmermans DR, van Bockel JH, Kievit J. 2004. Ideals of patient autonomy in clinical decision making: A study on the development of a scale to assess patients' and physicians' views. J Med Ethics 30: 268-274.
76. Summers AM. 1994. Informed choice in prenatal screening. Can Fam Physician 40: 1688-1691 1694-1697.
77. Tapon D. 2010. Prenatal testing for down syndrome: Comparison of screening practices in the UK and USA. J Genet Couns 19: 112-130.
78. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. 2010. College statement: Prenatal screening tests for trisomy 21 (down syndrome), trisomy 18 (Edwards syndrome) and neural tube defects.
79. van den Berg M, Timmermans DRM, ten Kate LP, van Vugt JMG, van der Wal G. 2006. Informed decision making in the context of prenatal screening. Patient Educ Couns 27: 110-117.
80. van den Heuvel A, Chitty L, Dormandy E, Newson A, Attwood S, Ma R, Masturzo B, Pajkrt E, Marteau TM. 2009. Is informed choice in prenatal testing universally valued? A population-based survey in europe and asia. BJOG 116: 880-885.
81. van der Zee B, de Beaufort I, Temel S, de Wert G, Denktas S, Steegers E. 2011. Preconception care: An essential preventive strategy to improve children's and women's health. J Public Health Policy 32: 367-379.
82. Weaver KD. 1997. Genetic screening and the right not to know. Issues Law Med 13: 243-279.
83. Williams C, Alderson P, Farsides B. 2002. Dilemmas encountered by health practitioners offering nuchal translucency screening: A qualitative case study. Prenat Diagn 22: 216-220.
84. Williams C, Sandall J, Lewando-Hundt G, Heyman B, Spencer K, Grellier R. 2005. Women as moral pioneers? Experiences of first trimester antenatal screening. Soc Sci Med 61: 1983-1992.
85. World Health Organization. 1998. Statement of WHO expert advisory group on ethical issues in medical genetics.
86. Wright CF, Burton H. 2009. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 15: 139-151.
87. Zindler L. 2005. Ethical decision making in first trimester pregnancy screening. J Perinat Neonatal Nurs 19: 122-131 (quiz 132-133).